Ginkgo Bioworks announced that it has raised $45 million in an oversubscribed Series B round. Viking Global led the round along with previous investors like OS Fund, Y Combinator and Felicis Ventures.
The new funds will be used to expand into new categories such as pharmaceuticals, cosmetics and probiotics, as well as hire employees and build out Bioworks 2, the next generation of Ginkgo's robotic Foundry.
